Navigation Links
Gabon establishes national ethics committee

This release is available in French.

As the number of health research conducted in sub-Saharan Africa increases, so does the need for improved review of the ethical and scientific rigour of these trials. As we work on increasing the quality of research, we should also work on ensuring the safety of research participants. The recently established National Bioethics Committee of Gabon, which was established with the help of a grant from the European and Developing Countries Clinical Trials Partnership (EDCTP), is an example of the progress made to safeguard the well-being of African study participants.

The newly formed National Bioethics Committee for research of Gabon currently comprises 19 members that represent the three main Gabonese research institutes (USS Libreville, URM Lambarene and CIRMF Franceville), as well as relevant Gabonese hospitals and ministries. This initiative was started with the help of an EDCTP grant, training support from the Vienna School of Clinical Research, the Government of the Republic of Gabon and a committed team of Gabonese nationals. Consequently, with complementary support of other partners including WHO, UNESCO, AMANET and the Institut Pasteur of Dakar the Committee was officially established.

The committee is now operational and anticipates starting reviewing protocols for clinical trials soon. Negotiations are currently underway to include the committee in UNESCO's Global Ethics Observatory Database. Inclusion in this database means that not only the Committee has proven able to assess research, but that is also able to advise on ethical problems, formulate recommendations and foster debate, education and public awareness.

Why every country must have a National Ethics Committee

All clinical trials involving human participants must be reviewed and approved by a competent and independent research ethics committee. The research ethics committee must ensure that all studies are conducted in accordance with international ethics codes and guidelines. The ultimate goal of ethical review is that the dignity, rights, safety and wellbeing of research participants are protected.

In many African countries, ethics review capacity needs to be strengthened. Inadequate training, limited infrastructural facilities and lack of funding remain a big challenge. As the number of clinical trials conducted in Africa is growing, so is the requirement to empower the countries of Africa to conduct their own safety reviews of those trials. Currently, a number of organisations such as EDCTP, WHO, UNESCO, AMANET, COHRED and others are working hand-in-hand to help those countries to create and strengthen their institutional and National Bioethics Committees.

EDCTP strengthening of ethics committees in Africa

EDCTP is involved in the assessment of the ethics and regulatory environment of the countries where EDCTP-funded trials will be conducted and provides support in these areas. The ultimate aim is to reinforce the African ethics and regulatory environment in the long term. EDCTP has funded research ethics committees in Zimbabwe, Ghana, Malawi, Nigeria, Uganda and Gabon and is working hand-in-hand with COHRED to map ethics and regulatory capacity in Africa and with the World Health Organization (WHO) to strengthen the National Regulatory framework.


Contact: Ilona van den Brink
Netherlands Organization for Scientific Research

Related medicine news :

1. Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
2. APTAs Multidisciplinary Summit Establishes Opportunities for Physical Therapists to Drive Health Care Change
3. Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers
4. Brooks Establishes Community Resource Center Web Site
5. Perceptive Informatics Establishes Alliance with AG Mednet to Bring Greater Efficiency and Quality to Medical Imaging-Based Trials
6. HPS Establishes Independent Website for its Patent-Pending Mood-Enhancing Compound Naturally Found in Sea Coral
7. Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico
8. Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation
9. Body-Jet Water-Assisted Liposuction Establishes New Standard for Liposuction and Fat Harvesting
10. Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.
11. Halleland Health Consulting Establishes URAC Accreditation Program
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm of ... obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer ... 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified that on ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... ... November 25, 2015 , ... Castlewood Treatment Center ... with eating disorders as a result of the $20,000 raised at the center’s ... Fox Run Golf Club in Eureka, will help individuals who otherwise might not ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development ... expansion of its current state of the art research, development and manufacturing facility ... increase its manufacturing capacity as well as to support its clients’ growing research ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Italian therapeutic drug monitoring ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: